Taipei Medical University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Taipei Taiwan (1960)

Organization Overview

First Clinical Trial
2003
NCT00628017
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Branch of Chinese Medicine, Taipei City Hospital | Chinese Medicine Dep, Taipei Hospital | Chun-Yao Huang | Department of Anesthesiolgy, Shuang-Ho Hospital, Taipei Medical University, Taiwan | Department of Neurology, Taipei Medical University Hospital, Taipei, Taiwan | Department of Psychiatry, Taipei City Hospital, Songde Branch, Taipei, Taiwan | Department of Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital | Department of Psychiatry, Taipei City Psychiatric Center, Taipei, Taiwan. | Department of Psychiatry, Taipei Psychiatric Center, Taipei City Hospital, Taipei, Taiwan | Department of Psychiatry, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan | Department of Psychosomatic Medicine, Taipei City Psychiatric Center, Taipei City Hospital | Department of Rehabilitation, Wan-Fang Hospital | Director, Division of Cancer Center, Wan Fang Hospital, Taiwan | Division of Nephrology, Department of Internal Medicine, Taipei Medical University Hospital | Gastroenterology division, Internal Medicine Department, Wanfang Hospital | Master Program in Global Health and Development, Taipei Medical University | Maternal Child Health Research Center, Taipei Medical University | New Taipei City Hospital | Office of Human Research, Taipei Medical University | Ren-Ai Branch, Taipei City Hospital | School of Nutrition and Health Sciences, Taipei Medical University, Taiwan | Section of Hematology-Oncology, Department of Medicine, Taipei Medical University Hospital | Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan | Shung Ho Hospital, Taipei Meidcal University | Song-De, Taipei City Hospital, Taiwan | Taipei City Hospital | Taipei City Hospital, Linsen Chinese Medicine & Kunming Branch, | taipei city hospital, taipei city goverment | taipei city hospital, tiapei city goverment | Taipei City Psychiatric Center | Taipei City Psychiatric Center, Taiwan | Taipei Hospital, Taiwan | Taipei Institute of Pathology | Taipei Medical Center | Taipei medical hospital, Linsen Chinese Medicine branch | Taipei Medical University | Taipei Medical University Graduate Institute of Metabolism and Obesity Sciences | Taipei Medical University Hospital | Taipei Medical University Muncipal Wan Fang Hospital | Taipei Medical University Shuang Ho Hospital | Taipei Medical University-ShuangHo Hospital | Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare | Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare,Taiwan | Taipei Medical University, Taiwan, R.O.C. | Taipei Medical University Wan Fang Hospital | Taipei Medical University WanFang Hospital | Taipei Medical University- Wan Fang Hospital | Taipei Medical University-Wan Fang Hospital | Taipei Medical University/Wan Fang Hospital | Taipei Medical University-WanFang Hospital, Taipei, Taiwan | Taipei Medical University Wang Fang Hospital | Taipei Medical Unviersity | Taipei Meidcal College | Taipei Municipal WanFang Hospital | Taipei Municipal Wanfang Hospital, Taipei, Taiwan | Tsai-Wei Huang | WanFangHospital | Wan Fang Hospital | Wanfang Hospital-Taipei Medical University | Wan Fang Hospital, Taipei, Taiwan | Wang Fang Hospital, Taipei Medical University | Wang Jing Hospital | YingHsuanTai

Active Ingredients

Drugs in Phase 4 Trials (40)

budesonide (rhinocort) (2 trials)

buprenorphine (1 trial)

cefazolin (ancef) (1 trial)

citalopram (celexa) (1 trial)

clozapine (clozaril) (2 trials)

dextrose (2 trials)

entecavir (baraclude) (2 trials)

escitalopram (lexapro) (1 trial)

esomeprazole (nexium) (1 trial)

ferric citrate (AURYXIA) (1 trial)

flurbiprofen (ansaid) (1 trial)

fluvoxamine (luvox) (1 trial)

garlic (2 trials)

glycopyrronium (robinul) (1 trial)

hyaluronic acid (4 trials)

indacaterol (arcapta neohaler) (1 trial)

interferon alpha-2b (Intron-A) (3 trials)

lidocaine (xylocaine) (4 trials)

lovastatin (mevacor) (1 trial)

methoxy polyethylene glycol-epoetin beta (Mircera) (1 trial)

multivitamins (1 trial)

naloxone (narcan) (1 trial)

nifedipine (procardia) (1 trial)

nivolumab (opdivo) (1 trial)

olmesartan (benicar) (1 trial)

paliperidone (invega) (1 trial)

paroxetine (paxil) (2 trials)

pentoxifylline (trental) (4 trials)

ribavirin (virazole) (1 trial)

risperidone (risperdal) (2 trials)

sevoflurane (ultane) (1 trial)

shen pu yang gan wan (1 trial)

sitagliptin (januvia) (2 trials)

surfactant (1 trial)

telmisartan (micardis) (1 trial)

tenofovir (viread) (3 trials)

tenofovir alafenamide (genvoya) (1 trial)

triamcinolone (kenalog) (4 trials)

valsartan (diovan) (1 trial)

zotepine (1 trial)

Drugs in Phase 3 Trials (21)

agaricus blazei murill (1 trial)

aripiprazole (abilify) (1 trial)

atorvastatin (lipitor) (1 trial)

chicken extract (1 trial)

digoxin (lanoxin) (1 trial)

droxidopa (northera) (1 trial)

empagliflozin (jardiance) (1 trial)

fructus schizandrae (1 trial)

ginseng (1 trial)

insulin glargine (toujeo) (1 trial)

insulin human (humulin) (1 trial)

ivabradine (corlanor) (1 trial)

kremezin (1 trial)

kuan sin yin (1 trial)

lamotrigine (lamictal) (1 trial)

l-epigallocatechin (6 trials)

methylprednisolone (medrol) (2 trials)

ophiochepalus striatus extract (1 trial)

pitavastatin (livalo) (1 trial)

pu yang wan wu tang (1 trial)

sweet potato (2 trials)

Drugs in Phase 2 Trials (30)

ad17002 (1 trial)

astragalus membranaceus (3 trials)

bevacizumab (avastin) (1 trial)

cisplatin (platinol) (2 trials)

Dimethylcurcumin (1 trial)

docetaxel (taxotere) (2 trials)

fluorouracil (efudex) (1 trial)

gemcitabine (gemzar) (1 trial)

gimeracil (1 trial)

irinotecan (Camptosar) (1 trial)

leucovorin (1 trial)

lipotecan (1 trial)

nemonoxacin (1 trial)

nicorandil (1 trial)

oteracil (1 trial)

oxaliplatin (eloxatin) (1 trial)

phy906 (1 trial)

pioglitazone (actos) (1 trial)

piperacetazine (quide) (1 trial)

piroxicam (feldene) (2 trials)

rifaximin (xifaxan) (1 trial)

s-1 (1 trial)

sarcosine (1 trial)

scb01a (1 trial)

sorafenib (nexavar) (1 trial)

sunitinib (sutent) (1 trial)

tamoxifen (nolvadex) (1 trial)

tegafur (1 trial)

tw1025 (1 trial)

zhibai dihuang (1 trial)

Drugs in Phase 1 Trials (15)

adagloxad simolenin (1 trial)

berry polyphenols (1 trial)

celecoxib (celebrex) (1 trial)

chidamide (1 trial)

ev71 vaccine (1 trial)

hlx06 (1 trial)

hlx55 (1 trial)

ibuprofen (motrin) (3 trials)

js014 (1 trial)

mpt0e028 (1 trial)

obi-833 (1 trial)

orax (1 trial)

pembrolizumab (keytruda) (1 trial)

sb cells (1 trial)

tt-00434 (1 trial)

Drugs in Other Trials (45)

acetaminophen (tylenol) (1 trial)

alfentanil (alfenta) (1 trial)

banana peel extract (1 trial)

bisacodyl (Halflytely) (1 trial)

branched chain amino acids (2 trials)

brown seaweed (1 trial)

calcitriol (rocaltrol) (1 trial)

carbamazepine (tegretol) (1 trial)

cilostazol (pletal) (1 trial)

cinacalcet (sensipar) (1 trial)

clopidogrel (plavix) (2 trials)

cow milk (1 trial)

dexamethasone (1 trial)

diclofenac (voltaren) (1 trial)

dopamine (intropin) (1 trial)

epinephrine (levophed) (1 trial)

ethambutol (myambutol) (1 trial)

fish oil (Omegavan) (2 trials)

folic acid (1 trial)

honey (2 trials)

icosapent ethyl (vascepa) (2 trials)

inactivated influenza vaccine (1 trial)

lactobacillus plantarum (1 trial)

medium chain triglyceride (1 trial)

mulberry leaf extract (3 trials)

naproxen (naprosyn) (1 trial)

oligo fucoidan (2 trials)

pine bark extract (1 trial)

pine cone extract (1 trial)

platelet-rich plasma (3 trials)

polyethylene glycol (1 trial)

propolis (2 trials)

pyrazinamide (Aldinamide) (1 trial)

qigong (1 trial)

rimabotulinumtoxinB (Myobloc) (1 trial)

ringer's lactate (1 trial)

sinphar lipucan (1 trial)

soybean (2 trials)

spirulina (2 trials)

spirulina platensis (1 trial)

tea (1 trial)

ticagrelor (brilinta) (1 trial)

timolol (blocadren) (1 trial)

vitamin d3 (1 trial)

wheat (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 2)

Acute Kidney Injury (Phase 3)

Amyotrophic Lateral Sclerosis (Phase 2)

Anorexia (Phase 2)

Atrial Fibrillation (Phase 3)

Back Pain (Phase 4)

Behavior, Addictive (Phase 3)

Blindness (Phase 3)

Bone Diseases, Metabolic (Phase 2)

Breast Neoplasms (Phase 2)

Bronchopulmonary Dysplasia (Phase 4)

Cachexia (Phase 2)

Carcinoma (Phase 4)

Carcinoma, Hepatocellular (Phase 4)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carpal Tunnel Syndrome (Phase 3)

Communicable Diseases (Phase 2)

Compulsive Personality Disorder (Phase 2)

Congenital Abnormalities (Phase 4)

Depression (Phase 4)

Depressive Disorder (Phase 2)

Depressive Disorder, Major (Phase 4)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Diabetic Foot (Phase 2)

Disease (Phase 2)

Enterovirus Infections (Phase 1)

Esophageal Neoplasms (Phase 2)

Fatigue (Phase 2)

Focal Infection (Phase 2)

Gastrointestinal Hemorrhage (Phase 4)

Head and Neck Neoplasms (Phase 2)

Heart Failure (Phase 3)

Hemorrhage (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hypercholesterolemia (Phase 3)

Hyperglycemia (Phase 3)

Hyperlipidemias (Phase 3)

Hyperlipoproteinemias (Phase 3)

Hyperphosphatemia (Phase 4)

Hypotension (Phase 3)

Hypotension, Orthostatic (Phase 3)

Infections (Phase 2)

Inflammation (Phase 4)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 4)

Low Back Pain (Phase 4)

Lung Diseases (Phase 4)

Lung Diseases, Obstructive (Phase 4)

Lung Neoplasms (Phase 2)

Malnutrition (Phase 4)

Metabolic Diseases (Phase 4)

Metabolic Syndrome (Phase 4)

Motor Neuron Disease (Phase 2)

Neoplasms (Phase 1)

Obesity (Phase 4)

Obsessive-Compulsive Disorder (Phase 2)

Opioid-Related Disorders (Phase 4)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Pancreatic Neoplasms (Phase 2)

Parkinson Disease (Phase 2)

Phosphorus Metabolism Disorders (Phase 4)

Pneumonia (Phase 3)

Pneumonia, Bacterial (Phase 3)

Psychotic Disorders (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Radiation Pneumonitis (Phase 2)

Renal Insufficiency (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Respiratory Distress Syndrome (Phase 4)

Respiratory Distress Syndrome, Newborn (Phase 4)

Rhinitis (Phase 2)

Rhinitis, Allergic (Phase 2)

Schizophrenia (Phase 4)

Sclerosis (Phase 2)

Stroke (Phase 3)

Syndrome (Phase 3)

Weight Loss (Phase 2)

Wounds and Injuries (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 137
  • # of Trial APIs: 151